Published in Otolaryngol Head Neck Surg on July 01, 2001
Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol (2006) 2.91
Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol (2006) 1.76
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A (2005) 1.74
HPV & head and neck cancer: a descriptive update. Head Neck Oncol (2009) 1.60
Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Arch Otolaryngol Head Neck Surg (2009) 1.27
Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.25
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol (2013) 1.17
Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system. Head Neck Pathol (2010) 1.16
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer (2011) 1.13
HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13
Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes. PLoS One (2012) 1.11
New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital (2013) 1.07
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res (2009) 1.06
Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. Expert Opin Med Diagn (2010) 1.03
Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer (2009) 1.02
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer (2011) 1.01
Evidence for a causal association for HPV in head and neck cancers. Eur Arch Otorhinolaryngol (2011) 1.01
High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health (2011) 0.98
The role of human papillomavirus in oral squamous cell carcinoma: myth and reality. Oral Maxillofac Surg (2012) 0.96
Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer Lett (2012) 0.96
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomarkers Prev (2008) 0.96
Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time. Chem Res Toxicol (2014) 0.96
An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control (2011) 0.94
A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma. Int J Oncol (2014) 0.88
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas. BMC Cancer (2015) 0.86
Update on molecular diagnostic tests in head and neck cancer. Semin Oncol (2008) 0.84
Race as a social construct in head and neck cancer outcomes. Otolaryngol Head Neck Surg (2011) 0.84
HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol (2008) 0.83
Distribution of human papillomavirus genotypes in sardinian patients with oral squamous cell carcinoma. Open Virol J (2010) 0.83
HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience. Int J Otolaryngol (2013) 0.83
Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2010) 0.82
HPV and cancer of the oral cavity. Virulence (2015) 0.82
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes. Radiat Oncol (2013) 0.81
The role of sexual behavior in head and neck cancer: implications for prevention and therapy. Expert Rev Anticancer Ther (2014) 0.81
Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol (2010) 0.80
Evidences suggesting involvement of viruses in oral squamous cell carcinoma. Patholog Res Int (2013) 0.80
Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot study. BMC Oral Health (2012) 0.79
Head and neck cancer in HIV patients and their parents: a Danish cohort study. Clin Epidemiol (2011) 0.79
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. Infect Agent Cancer (2011) 0.79
Survival trends in head and neck cancer: opportunities for improving outcomes. Oncologist (2010) 0.79
Human papillomavirus prevalence in invasive laryngeal cancer in the United States. PLoS One (2014) 0.79
Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program. Int J Radiat Oncol Biol Phys (2007) 0.78
Molecular characterization of head and neck cancer: how close to personalized targeted therapy? Mol Diagn Ther (2012) 0.78
The use of epidermal growth factor receptor monoclonal antibodies in squamous cell carcinoma of the head and neck. Chemother Res Pract (2012) 0.77
HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients. Infect Agent Cancer (2016) 0.77
Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer. Head Neck Pathol (2012) 0.77
Concern Oral sex, cancer and death: sexually transmitted cancers. Head Neck Oncol (2012) 0.76
Chronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis. PLoS One (2015) 0.76
A shifting paradigm in the aetiology of oral and pharyngeal cancer in Sri Lanka: a case-control study providing serologic evidence for the role of oncogenic HPV types 16 and 18. Infect Agent Cancer (2015) 0.75
Correlation of human papilloma virus with oral squamous cell carcinoma in Chinese population. Int J Clin Exp Med (2015) 0.75
De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review. Oncol Lett (2015) 0.75
Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment-a Pilot Study from Northern India. Indian J Surg Oncol (2016) 0.75
Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx. J Biomed Res (2010) 0.75
Recent advances in managing human papillomavirus-positive oropharyngeal tumors. F1000 Med Rep (2010) 0.75
p16(INK4A) expression in invasive laryngeal cancer. Papillomavirus Res (2016) 0.75
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (1998) 7.81
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med (1997) 4.21
Selection and characterization of bovine aortic endothelial cells. In Vitro (1978) 4.09
BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry (1994) 3.75
Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (1996) 3.61
Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol (1988) 3.54
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Biochemical transformation of mouse cells by fragments of herpes simplex virus DNA. Cell (1977) 3.38
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Replication of smooth muscle cells in vascular disease. Circ Res (1986) 2.98
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol (2000) 2.77
Correlation between tumor induction and the large external transformation sensitive protein on the cell surface. Proc Natl Acad Sci U S A (1976) 2.76
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2001) 2.73
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science (1986) 2.67
Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest (1992) 2.62
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60
International system for human gene nomenclature (1979) ISGN (1979). Cytogenet Cell Genet (1979) 2.58
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51
Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest (1981) 2.46
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA (1995) 2.43
Expression of the sis gene by endothelial cells in culture and in vivo. Proc Natl Acad Sci U S A (1984) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res (1991) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci U S A (1991) 2.38
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst (1995) 2.36
Clinical characteristics of different histologic types of breast cancer. Br J Cancer (2005) 2.36
Developmentally regulated production of platelet-derived growth factor-like molecules. Nature (1984) 2.30
Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res (1985) 2.28
Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol (1994) 2.26
The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature (1983) 2.26
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol (1990) 2.26
Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A (1983) 2.26
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23
Detection of herpes simplex RNA in human sensory ganglia. Virology (1979) 2.23
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol (2001) 2.18
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15
Limited transcription of the herpes simplex virus genome when latent in human sensory ganglia. J Virol (1982) 2.12
Risk factors for sudden infant death syndrome: changes associated with sleep position recommendations. J Pediatr (2001) 2.09
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest (1995) 2.02
Cell replication in the aortic endothelium: a new method for study of the problem. Lab Invest (1973) 1.99
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer (2005) 1.96
Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst (2001) 1.95
Cervical cancer screening among Cambodian-American women. Cancer Epidemiol Biomarkers Prev (1999) 1.95
Correlates of homosexual behavior and the incidence of anal cancer. JAMA (1982) 1.95
Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest (1996) 1.94
An endothelial cell-derived growth factor. J Cell Biol (1980) 1.93
Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A (1988) 1.92
Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. Paediatr Perinat Epidemiol (1996) 1.91
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 1.89
Renal injury from angiotensin II-mediated hypertension. Hypertension (1992) 1.88
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol (1982) 1.88
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (2000) 1.83
Perinatal factors and risk of breast cancer. Epidemiology (1996) 1.82
Case-control differences in the reliability of reporting a history of induced abortion. Am J Epidemiol (2000) 1.82
Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol (2000) 1.82
Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer (1999) 1.82
Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. J Gen Virol (1989) 1.78
Prenatal care and pregnancy outcomes during the recession: the Washington State experience. Am J Public Health (1985) 1.76
Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer (2000) 1.75
Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest (1983) 1.75
Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol (1994) 1.74
Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst (1987) 1.74
Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res (1994) 1.73
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Infant mortality among subsequent siblings of infants who died of sudden infant death syndrome. J Pediatr (1986) 1.70
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Use of electric blankets and risk of testicular cancer. Am J Epidemiol (1990) 1.69
Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med (1985) 1.69
In situ hybridization of adenovirus RNA and DNA. Nature (1972) 1.66
Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol (1994) 1.65
Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum (1993) 1.64